Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
In development
In development: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic prioritisation
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Expected publication date
Expected publication date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (1)
Type
Type
Guidance (11)
Guidance programme
Guidance programme
Diagnostics guidance (2)
Health technology evaluations (2)
Interventional procedures guidance (1)
Technology appraisal guidance (8)
Apply filters
Showing 1 to 10 of 11
Sort by
Title
Date
Apply sorting
Keyword or reference number: surgery
Remove Keyword or reference number: surgery filter
Guidance, NICE advice and quality standards in development
Title
Type
Expected publication date
Atezolizumab with BCG before
surgery
(neoadjuvant) for treating non-muscle-invasive bladder cancer [ID6667]
Technology appraisal guidance
TBC
Cemiplimab for adjuvant treatment of high-risk cutaneous squamous cell carcinoma after
surgery
and radiotherapy [ID6659]
Technology appraisal guidance
TBC
Corticosteroid-releasing bioabsorbable stent or spacer insertion during endoscopic sinus
surgery
to treat chronic rhinosinusitis
Interventional procedures guidance
TBC
Digital platforms to support rehabilitation before and after primary elective hip or knee replacement
surgery
Health technology evaluation
11 August 2026
Durvalumab with gemcitabine and cisplatin before
surgery
(neoadjuvant) then alone after
surgery
(adjuvant) for treating muscle-invasive bladder cancer [ID6168]
Technology appraisal guidance
TBC
Monofocal intraocular lenses for cataract
surgery
(provisional title)
Health technology evaluation
TBC
Pembrolizumab before
surgery
(neoadjuvant) then with radiotherapy after
surgery
(adjuvant) for newly diagnosed, resectable, locally advanced, squamous cell head and neck cancer [ID6477]
Technology appraisal guidance
TBC
Pembrolizumab for adjuvant treatment of locally advanced cutaneous squamous cell carcinoma after
surgery
and radiotherapy ID 6473
Technology appraisal guidance
TBC
Pembrolizumab with chemotherapy for adjuvant treatment of newly diagnosed high-risk endometrial cancer after
surgery
with curative intent [ID6207]
Technology appraisal guidance
TBC
Vimseltinib for treating tenosynovial giant cell tumours when
surgery
is unsuitable TSID 12099
Technology appraisal guidance
TBC
Current page
1
2
Page
1
of
2
Next page
Results per page
10
25
50
All
Back to top